# Effect of metabolites on the survival and biofilm formation of Pantoea piersonii (Basionym: Kalamiella piersonii) in synthetic urine media

**Authors:** Yuvarajan Subramaniyan, K. S. Megha, K. Adithyan, Rajendu R. Nair, M. Mujeeburahiman, Blessy M. Baby, Pallavi Poojarira Ganesh, Punchappady Devasya Rekha

PMC · DOI: 10.1186/s12866-025-04684-z · BMC Microbiology · 2026-01-20

## TL;DR

This study shows how Pantoea piersonii adapts to different urinary conditions by growing, forming biofilms, and breaking down urea.

## Contribution

The study reveals P. piersonii's urea tolerance and biofilm formation under varying synthetic urine conditions.

## Key findings

- P. piersonii growth and biofilm formation increased significantly with higher urea concentrations.
- Glucose and creatinine together enhanced growth and biofilm formation more than either alone.
- P. piersonii outcompeted E. coli in dual-species biofilms, showing a competitive advantage in the urinary tract.

## Abstract

Pantoea piersonii (Basionym: Kalamiella piersonii) is an opportunistic pathogen capable of forming strong biofilms and infecting diverse anatomical sites. In this study, we investigated the growth, biofilm forming ability and ureolytic activity of P. piersonii under different growth conditions using synthetic urine to test its adaptability under different urinary conditions. We used P. piersonii strain YU22, isolated from the urine of a patient with kidney stone disease, and cultured under different urea concentrations (10 mM − 420 mM) to evaluate urea tolerance. Glucose, creatinine, and albumin were supplemented in synthetic urine to simulate the glycosuria, creatinuria, and albuminuria. Additionally, the effect of urinary pH variation was examined by adjusting the media to pH 5, pH 7, and pH 8. To investigate the ability of P. piersonii to co-exist with other key uropathogenic bacteria, we used a uropathogenic Escherichia coli, in a co-culture experiment. Under all the tested conditions, the growth, biofilm formation, and ureolytic activity were quantified using standard methods. Expression of urea carboxylase and allophanate hydrolase, in the selected conditions was analyzed using qRT-PCR. P. piersonii was able to tolerate urea at all the tested concentrations, showing a significant increase in growth (OD600) with increasing concentrations of urea from 0.19 ± 0.01 (10 mM) to 0.59 ± 0.01 (420 mM) (p < 0.01). Biofilm formation measured by crystal violet staining method also showed significant increase with OD590 values from 10 mM (0.55 ± 0.03) to 420 mM urea (1.74 ± 0.05) (p < 0.01). Among the nutritional supplements the highest growth and biofilm formation was observed in glucose, followed by creatinine and albumin. The combination of glucose with creatinine resulted in 25% and 30% increase in growth, respectively, compared to media containing glucose or creatinine separately. pH 7 favored growth and biofilm formation in all the tested conditions, except in the presence of glucose. Growth response and ureolytic activity varied significantly with changes in the nutritional composition and pH of the media (p < 0.05). In dual-species biofilm environment, P. piersonii dominated over E. coli under the tested growth conditions, suggesting a competitive advantage in the urinary environment that may influence community structure in mixed-species biofilms. These results demonstrate that the survival mechanism and ureolytic activity of P. piersonii are complex with the ability to adapt to varying environmental conditions in response to nutrient availability to enable survival under extreme conditions. However, these preliminary findings require validation through further investigations.

The online version contains supplementary material available at 10.1186/s12866-025-04684-z.

## Linked entities

- **Chemicals:** urea (PubChem CID 1176), glucose (PubChem CID 5793), creatinine (PubChem CID 588)
- **Species:** Pantoea piersonii (taxon 2364647), Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** metabolic (MESH:D008659), alkalosis (MESH:D000471), emphysematous pyelonephritis (MESH:D011704), Glycosuria (MESH:D006029), chronic granulomatous disease (MESH:D006105), kidney disorders (MESH:D007674), kidney stone disease (MESH:D007669), vascular dysfunction (MESH:D002561), UTI (MESH:D014552), chronic kidney disease (MESH:D051436), infection (MESH:D007239), bacteremia (MESH:D016470), diabetes (MESH:D003920), opportunistic human infections (MESH:D009894), Albuminuria (MESH:D000419)
- **Chemicals:** creatinine (MESH:D003404), formaldehyde (MESH:D005557), Glucose (MESH:D005947), sarcosine (MESH:D012521), glycine (MESH:D005998), KCl (MESH:D011189), CaCl2 (MESH:D002122), acetic acid (MESH:D019342), iron (MESH:D007501), (NH4)2SO4 (MESH:D000645), CO2 (MESH:D002245), agar (MESH:D000362), methylamine (MESH:C027451), carbon (MESH:D002244), sodium hypochlorite (MESH:D012973), CAS (MESH:C015076), creatine (MESH:D003401), lactose (MESH:D007785), Na2SO4 (MESH:C012036), FITC (MESH:D016650), polysaccharide (MESH:D011134), ammonium (MESH:D064751), Urea (MESH:D014508), nitrogen (MESH:D009584), sodium citrate (MESH:D000077559), ammonia (MESH:D000641), sodium (MESH:D012964), acridine orange (MESH:D000165), 2H2O (-), MgCl2 (MESH:D015636), acridine (MESH:D000166), sodium oxalate (MESH:D019815), crystal violet (MESH:D005840), methanol (MESH:D000432), NaCl (MESH:D012965)
- **Species:** Pantoea agglomerans (species) [taxon 549], Streptococcus salivarius (species) [taxon 1304], Pantoea (genus) [taxon 53335], Pantoea ananatis (species) [taxon 553], Streptococcus pneumoniae (species) [taxon 1313], Serratia (genus) [taxon 613], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Proteus mirabilis (species) [taxon 584], Helicobacter pylori (species) [taxon 210], Yersinia enterocolitica (species) [taxon 630], Granulibacter bethesdensis (species) [taxon 364410], Mycobacterium tuberculosis (species) [taxon 1773], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Pseudomonas aeruginosa (species) [taxon 287], Escherichia coli (E. coli, species) [taxon 562], Pantoea sp. YU22 (species) [taxon 2497684], Candida albicans (species) [taxon 5476]
- **Mutations:** Y50E
- **Cell lines:** YU22 — Mus musculus (Mouse), Hybridoma (CVCL_B4FN)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12951989/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12951989/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12951989/full.md

---
Source: https://tomesphere.com/paper/PMC12951989